Hyderabad, 5^th November 2020: Esperer Onco Nutrition (EON) announced the appointment of Ms. Madhumita Manna as Vice President, Consumer Health Division.  With more than two decades of experience in leadership roles across industries Ms. Manna’s appointment will be instrumental in understanding the micros and macros of trends, inter-disciplinary dynamics and strategies going forward for Esperer Nutrition. Esperer Onco Nutrition (EON) is  clinical Nutrition  organisation headquartered in Mumbai having its own R&D centre in Hyderabad.

A highly skilled and result-driven professional, Ms. Madhumita is an IIM-Calcutta alumnus in Business Management. She has led and managed profit centres for companies like Pfizer, Torrent Pharma & DRL in in the pharmaceutical industry. Her leadership role at Esperer will help EON in making turn-key decisions related to new market creation, innovative business modelling and insight-based strategies. Her passion for comprehending, analyzing and formulating strategies based on market trends and consumer dynamics will help streaming Esperer’s larger business strategy. “I am excited to have commenced work with Esperer Onco Nutrition (EON). I am hoping to contribute to building a stable foundation and offer a podium fertile with growth potential for the research organization keeping their objectives in mind”, said Ms. Madhumita Manna.

Mr. Raktim Chattopadhyay, Founder & CEO said, “We were looking for a leader with intrinsic experience in the Nutraceutical space along with hands-on experience in market and business strategy in  industry. We have found the best. I am looking forward to work with Ms. Madhumita as Vice-President, her know-how could pave a promising and brighter future over evidence based clinical Nutrition consumer market segment .”

Esperer Nutrition strives to champion the role of nutritional therapies that have proven clinical & health economic value & improve the quality of people’s lives. EON is destined to understand, treat & help prevent a range of medical conditions by leveraging nutrition and life sciences.  Company  aims to address specific health conditions with special emphasis on Onco Nutrition &  intend to provide a 360 degree solution to global cancer portfolio right from Preventive Oncology to Cancer Disease Management using Nutraceutical as complementary therapy to stage & region specific cancer patients. EON aspire to become global pioneer considering Drug-Nutrient Interaction as major factor in chronic  disease management.

The post Esperer Onco Nutrition (EON) appoints Madhumita Manna as vice president – consumer health appeared first on Health Vision.

Community acquired respiratory viral infections (CRV) can increase morbidity, mortality in some critical disease conditions like cancer. These are the result of infections with a heterogeneous group of viruses including RNA viruses, such as respiratory syncytial virus (RSV), influenza virus (IV), parainfluenza virus (PIV), metapneumovirus (HMPV), rhinovirus (RhV), and coronavirus (CoV).Infections due to recent COVID 19 outbreak maintain similar seasonal pattern to those of immunocompetent patients. Clinical manifestations vary significantly depending on type and degree of immunosuppression, from upper to lower respiratory tract infection and prolonged viral shedding.

Use of corticosteroids and immunosuppressive therapy are risk factors for severe disease. The clinical course is often difficult to predict, and clinical signs are unreliable. Accurate prognostic viral and immune markers, which have become part of the standard of care for systemic viral infections, are currently lacking; and management of CRV infections like COVID 19 remains controversial. Defining effective prophylactic and therapeutic strategies are challenging, especially considering, the spectrum of immunocompromised patients, the variety of respiratory viruses, and the presence of other opportunistic infections and medical problems.

Prevention remains one of the most important strategies against such viruses. Early diagnosis, supportive care and antivirals at an early stage, when available and indicated, have proven beneficial. In high-risk patients, pre-emptive treatment with antivirals for upper respiratory tract infection (URTI) to decrease progression to LRTI is a common strategy. In the future, viral load and immune markers may prove beneficial in predicting the disease, supporting decision making and monitor treatment in this case.

Nutrition and professional support on diet:

In fact the time respiratory manifestation comes as symptom (systemic) inflammation of the airways, impaired lung function, airflow obstruction, morbidity and mortality. Patient can be at risk of fragility, because the disease and the lack of oxygen also consumes muscles. Therefore, and especially clinical nutrition is needed to ensure proteins, vitamins and minerals are provided. The disease also ‘consumes more’ of these and therefore nutrition and professional support on diet is needed. When people with COVID19 have other chronic diseases like diabetes or heart disease which also come with a specific dietary guidance and nutritional intervention become critical and significant.

We must not forget respiratory infection is the one which become deadly reason for COVID 19 infection. Although the respiratory tract is the third-commonest site of infection in the body, it is the commonest site of fatal infections, which often represent the ‘final common pathway’ complicating the many effects of under-nutrition. For example, deaths among the malnourished with CRV like corona are frequently due to pneumonia. The D vitamins have demonstrated protective effect in preventing lung infections in many studies.

Hence, along with greater research and inventions of Corona prevention/management in medicines, equal encouragement  of nutritional intervention should be persuaded as effective prevention from such deadly viral  infections in the field of research and innovation.

Mr. Raktim Chattopadhyay

(Post graduate Human Physiology & specialised in Medical Nutrition)

Founder & CEO, Esperer Onco Nutrition

The post Nutritional intervention can be effective prevention for COVID 19 appeared first on Health Vision.